vs
Hudson Pacific Properties, Inc.（HPP）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Hudson Pacific Properties, Inc.的季度营收约是Orthofix Medical Inc.的1.2倍（$256.0M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -109.4%，领先108.4%），Hudson Pacific Properties, Inc.同比增速更快（22.1% vs 2.0%），过去两年Hudson Pacific Properties, Inc.的营收复合增速更高（13.0% vs 8.0%）
哈德逊太平洋地产是一家房地产投资信托企业，持有1580万平方英尺办公楼、150万平方英尺摄影棚，同时拥有300万平方英尺商用物业的未开发权益，资产布局覆盖美国西海岸及温哥华，注册地位于马里兰州，总部设在洛杉矶，是洛杉矶当地规模最大的独立摄影棚运营商。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
HPP vs OFIX — 直观对比
营收规模更大
HPP
是对方的1.2倍
$219.9M
营收增速更快
HPP
高出20.1%
2.0%
净利率更高
OFIX
高出108.4%
-109.4%
两年增速更快
HPP
近两年复合增速
8.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $256.0M | $219.9M |
| 净利润 | $-280.2M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 18.6% | 0.2% |
| 净利率 | -109.4% | -1.0% |
| 营收同比 | 22.1% | 2.0% |
| 净利润同比 | -61.5% | 92.4% |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HPPOFIX
| Q3 26 | $256.0M | — | ||
| Q1 26 | $181.9M | — | ||
| Q4 25 | $256.0M | $219.9M | ||
| Q3 25 | $186.6M | $205.6M | ||
| Q2 25 | $190.0M | $203.1M | ||
| Q1 25 | $198.5M | $193.6M | ||
| Q4 24 | $209.7M | $215.7M | ||
| Q3 24 | $200.4M | $196.6M |
净利润HPPOFIX
| Q3 26 | $-280.2M | — | ||
| Q1 26 | $-50.9M | — | ||
| Q4 25 | $-280.2M | $-2.2M | ||
| Q3 25 | $-144.1M | $-22.8M | ||
| Q2 25 | $-87.8M | $-14.1M | ||
| Q1 25 | $-80.3M | $-53.1M | ||
| Q4 24 | $-173.5M | $-29.1M | ||
| Q3 24 | $-107.0M | $-27.4M |
毛利率HPPOFIX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 60.0% | 71.1% | ||
| Q3 25 | 44.3% | 72.2% | ||
| Q2 25 | 43.1% | 68.7% | ||
| Q1 25 | 42.9% | 62.8% | ||
| Q4 24 | 44.7% | 69.0% | ||
| Q3 24 | 42.7% | 68.7% |
营业利润率HPPOFIX
| Q3 26 | 18.6% | — | ||
| Q1 26 | -7.1% | — | ||
| Q4 25 | -109.8% | 0.2% | ||
| Q3 25 | -77.2% | -8.3% | ||
| Q2 25 | -46.0% | -7.9% | ||
| Q1 25 | -40.4% | -25.2% | ||
| Q4 24 | -83.2% | -5.3% | ||
| Q3 24 | -52.3% | -9.6% |
净利率HPPOFIX
| Q3 26 | -109.4% | — | ||
| Q1 26 | -28.0% | — | ||
| Q4 25 | -109.4% | -1.0% | ||
| Q3 25 | -77.2% | -11.1% | ||
| Q2 25 | -46.2% | -6.9% | ||
| Q1 25 | -40.5% | -27.4% | ||
| Q4 24 | -82.7% | -13.5% | ||
| Q3 24 | -53.4% | -13.9% |
每股收益（稀释后）HPPOFIX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-11.57 | $-0.05 | ||
| Q3 25 | $-0.30 | $-0.57 | ||
| Q2 25 | $-0.41 | $-0.36 | ||
| Q1 25 | $-0.53 | $-1.35 | ||
| Q4 24 | $-1.19 | $-0.76 | ||
| Q3 24 | $-0.69 | $-0.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $138.4M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.2B | $450.0M |
| 总资产 | $7.3B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HPPOFIX
| Q3 26 | $138.4M | — | ||
| Q1 26 | $138.0M | — | ||
| Q4 25 | $138.4M | $82.0M | ||
| Q3 25 | $190.4M | $62.9M | ||
| Q2 25 | $236.0M | $65.6M | ||
| Q1 25 | $86.5M | $58.0M | ||
| Q4 24 | $63.3M | $83.2M | ||
| Q3 24 | $90.7M | $30.1M |
总债务HPPOFIX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M |
股东权益HPPOFIX
| Q3 26 | $3.2B | — | ||
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.0B | $450.0M | ||
| Q3 25 | $3.2B | $442.5M | ||
| Q2 25 | $3.4B | $458.3M | ||
| Q1 25 | $2.8B | $458.3M | ||
| Q4 24 | $2.9B | $503.1M | ||
| Q3 24 | $3.0B | $525.9M |
总资产HPPOFIX
| Q3 26 | $7.3B | — | ||
| Q1 26 | $7.2B | — | ||
| Q4 25 | $7.3B | $850.6M | ||
| Q3 25 | $7.8B | $832.6M | ||
| Q2 25 | $8.1B | $837.2M | ||
| Q1 25 | $8.0B | $823.1M | ||
| Q4 24 | $8.1B | $893.3M | ||
| Q3 24 | $8.3B | $867.9M |
负债/权益比HPPOFIX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | 14.0% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流HPPOFIX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $121.0M | $27.7M | ||
| Q3 25 | $33.2M | $12.4M | ||
| Q2 25 | $-2.0M | $11.6M | ||
| Q1 25 | $30.5M | $-18.4M | ||
| Q4 24 | $164.7M | $23.7M | ||
| Q3 24 | $63.7M | $11.7M |
自由现金流HPPOFIX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M |
自由现金流率HPPOFIX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% |
资本支出强度HPPOFIX
| Q3 26 | 14.0% | — | ||
| Q1 26 | 18.5% | — | ||
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HPP
| Rental revenues | $216.8M | 85% |
| Other | $35.6M | 14% |
| Service and other revenues | $3.7M | 1% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
